How is the Processa Pharmaceuticals Inc today?

The Processa Pharmaceuticals Inc today is trading in the down by -3.33% at 0.29.

What is Processa Pharmaceuticals Inc Annual Net Profit?

Processa Pharmaceuticals Inc Annual Net Profit fell 6.55% in the last year to $11.85 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Processa Pharmaceuticals Inc Price to Earning Ratio?

Processa Pharmaceuticals Inc Price to Earning Ratio is -0.29, which is negative.

What is Processa Pharmaceuticals Inc Stock Price?

Processa Pharmaceuticals Inc Stock Price fell 81.65% and underperformed its sector by 137.12% in the past year.

What is Processa Pharmaceuticals Inc Quarterly Net profit?

Processa Pharmaceuticals Inc Quarterly Net profit fell 3.96% YoY to $2.83 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Processa Pharmaceuticals Inc Debt to Equity Ratio?

Processa Pharmaceuticals Inc Debt to Equity Ratio of 0.04 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Processa Pharmaceuticals Inc Return on Equity(ROE)?

Processa Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was -354.51%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Processa Pharmaceuticals Inc Mutual Fund Holding?

Processa Pharmaceuticals Inc Mutual Fund Holding increased by 0.13% in the last quarter to 1.4.

What is Processa Pharmaceuticals Inc Institutional Holding?

Processa Pharmaceuticals Inc Institutional Holding increased by 1.32% in the last quarter to 3.39.

Processa Pharmaceuticals Inc XNAS: PCSA

Processa Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Processa Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Processa Pharmaceuticals Inc
Rating: 1.15608325
Author: Trendlyne DVM scores

about

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is...

0.29 -0.01 (-3.33%)

90.65% Fall from 52W High

3.5M XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

11.3 / 100

Technically Bearish

34.9 / 100

No estimates available

Processa Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Processa Pharmaceuticals Inc FAQ

How is Processa Pharmaceuticals Inc today?

Processa Pharmaceuticals Inc today is trading in the red, and is down by -3.33% at 0.29.

How has Processa Pharmaceuticals Inc performed historically?

Processa Pharmaceuticals Inc is currently trading down -3.33% on an intraday basis. In the past week the stock rose 20.83%. stock has been down -46.30% in the past quarter and fell -81.65% in the past year. You can view this in the overview section.